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Type B adverse drug reactions (ADRs) are iatrogenic immune-mediated syndromes
with mechanistic etiologies that remain incompletely understood. Some of the most
severe ADRs, including delayed drug hypersensitivity reactions, are T-cell mediated,
restricted by specific human leukocyte antigen risk alleles and sometimes by public
or oligoclonal T-cell receptors (TCRs), central to the immunopathogenesis of tissue-
damaging response. However, the specific cellular signatures of effector, regulatory,
and accessory immune populations that mediate disease, define reaction phenotype,
and determine severity have not been defined. Recent development of single-cell
platforms bringing together advances in genomics and immunology provides the
tools to simultaneously examine the full transcriptome, TCRs, and surface protein
markers of highly heterogeneous immune cell populations at the site of the pathological
response at a single-cell level. However, the requirement for advanced bioinformatics
expertise and computational hardware and software has often limited the ability of
investigators with the understanding of diseases and biological models to exploit
these new approaches. Here we describe the features and use of a state-of-the-art,
fully integrated application for analysis and visualization of multiomic single-cell data
called Visual Genomics Analysis Studio (VGAS). This unique user-friendly, Windows-
based graphical user interface is specifically designed to enable investigators to
interrogate their own data. While VGAS also includes tools for sequence alignment
and identification of associations with host or organism genetic polymorphisms, in this
review we focus on its application for analysis of single-cell TCR–RNA–Cellular Indexing
of Transcriptomes and Epitopes by Sequencing (CITE)-seq, enabling holistic cellular
characterization by unbiased transcriptome and select surface proteome. Critically,
VGAS does not require user-directed coding or access to high-performance computers,
instead incorporating performance-optimized hidden code to provide application-based
fast and intuitive tools for data analyses and production of high-resolution publication-
ready graphics on standard specification laptops. Specifically, it allows analyses of
comprehensive single-cell TCR sequencing (scTCR-seq) data, detailing (i) functional
pairings of α–β heterodimer TCRs, (ii) one-click histograms to display entropy and gene
rearrangements, and (iii) Circos and Sankey plots to visualize clonality and dominance.
For unbiased single-cell RNA sequencing (scRNA-seq) analyses, users extract cell
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transcriptome signatures according to global structure via principal component analysis,
t-distributed stochastic neighborhood embedding, or uniform manifold approximation
and projection plots, with overlay of scTCR-seq enabling identification and selection
of the immunodominant TCR-expressing populations. Further integration with similar
sequence-based detection of surface protein markers using oligo-labeled antibodies
(CITE-seq) provides comparative understanding of surface protein expression, with
differential gene or protein analyses visualized using volcano plot or heatmap functions.
These data can be compared to reference cell atlases or suitable controls to reveal
discrete disease-specific subsets, from epithelial to tissue-resident memory T-cells,
and activation status, from senescence through exhaustion, with more finite transcript
expression displayed as violin and box plots. Importantly, guided tutorial videos
are available, as are regular application updates based on the latest advances in
bioinformatics and user feedback.
Keywords: bioinformatics, heterogeneity, immunogenomics, single-cell TCR sequencing, single-cell RNA
sequencing, single-cell CITE-seq
INTRODUCTION TO VISUAL GENOMICS
ANALYSIS STUDIO: ANALYSIS AND
VISUALIZATION OF MULTIDIMENSIONAL
SINGLE-CELL SEQUENCING DATA
Understanding the immunogenic risk factors associated with
immune-mediated disease has seen significant progress in recent
decades, linked to the rapid and continued development of
genomic sequence–based technologies initially at a bulk and
more recently at a single-cell level. While progress spans an
entire spectrum of immune disease, T-cell–mediated delayed
drug hypersensitivity reactions (DHRs) stand out as some of
the strongest associations with distinct human leukocyte antigen
(HLA) alleles. These HLA associations are specific to reaction
phenotype, drug, and patient ethnicity (Chung et al., 2004;
Lonjou et al., 2006; Wu et al., 2016; Nakkam et al., 2018;
Konvinse et al., 2019). However, for all associations to date,
a positive predictive gap remains (Phillips, 2018), limiting the
clinical impact of HLA screening for particular drugs and our
understanding of reaction mechanisms, driving active research
to identify those additional risk parameters imposed on HLA-
restricted response. In 2019, a role for specific T-cell receptor
(TCR) clonotypes among the expansive human repertoire was
reported by Pan et al., who detailed expression of a single,
dominant, public TCR in the reacted skin of patients with HLA-
B∗15:02-restricted carbamazepine Stevens–Johnson syndrome
and toxic epidermal necrolysis (SJS/TEN), but which was absent
from tolerant controls and healthy donors (Pan et al., 2019).
Using genetic engineering to insert a synthetic construct of the
dominant TCR into a murine drug-exposure model, they showed
that this TCR recognized carbamazepine, functionally validating
the risk TCR as a key driver of early drug-specific response
in tissue. Aside from inferring critical structural restriction
regarding binding of the drug and/or peptide by the HLA
and TCR molecules to bridge the immunological synapse, the
dominantly expanded TCR may serve as a functional biomarker
to identify and characterize the specific effector populations
driving disease. Cost-effective genetic screening pipelines for
HLA and other polymorphic genes see continued clinical
progress toward better genetic risk prediction (Rauch et al., 2006;
Chen et al., 2011; Plumpton et al., 2015). However, mechanistic
understanding of these reactions has been hampered by limited
availability of singular platforms for fully integrated user-friendly
analyses by the non-coding-proficient researcher. Techniques
including flow cytometry, microscopy, in situ hybridization,
and more recently mass cytometry have been utilized, yielding
insights into the phenotype of cells participating in response,
but have not simultaneously characterized the TCRs and
transcriptome and surface protein markers at a single-cell level
(Chattopadhyay et al., 2014). Comparatively, sequencing-based
strategies have delivered unrivaled opportunity as markers are
tagged with synthetic DNA barcodes, providing truly limitless
sequence combinations for high-dimensional detection of RNA
or protein, or indeed distinct pooled (“hashed”) samples to
enhance cost efficiency per run. These techniques were initially
applied to bulk analyses, providing average expression across
an entire sample and so potentially hiding response from
individual effector populations preventing resolution from total
sample expression. Thus, as with all bulk assays, opportunity to
detail the true complex cellular heterogeneity of clinical samples
was lost, but which is integral to complete understanding of
disease as immune interactions are complex and continuously
regulated by intercell interactions and secretions. Concurrent
with advances in cell sorting and droplet technologies, single-
cell sequencing by Smart-Seq2 and 10x platforms, respectively,
now provide information for each and every cell (Nguyen et al.,
2018; Svensson et al., 2018). With the support of bioinformatics-
driven algorithms, the complete transcriptomic signature of
each cell provides means to cluster similar cells without user-
directed imposition of preconceived expression, which, when
aligned to the open-access human cell atlas under continued
development, enables verification of subsets identified through
unsupervised clustering for user-directed signature analyses.
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Already this technology is revealing a spectrum of heterogeneous
clusters within previously thought homogeneous populations
(Villani et al., 2017), driving immunogenic discovery across the
spectrum of immune-mediated diseases. These platforms now
present as fully integrated, multifocal pipelines for simultaneous
assessment of (i) unbiased transcriptome (single-cell RNA
sequencing; scRNA-seq), (ii) select surface proteome (single-
cell Cellular Indexing of Transcriptomes and Epitopes by
Sequencing; scCITE-seq), and, for T-cells, (iii) functional TCR
(single-cell TCR sequencing; scTCR-seq) α–β pairings with
VDJ complementarity determining region 3 (CDR3) inference
of antigen restriction. Importantly, aside from discovery
analyses via differential expression, investigational studies can be
performed on interest markers in distinct subpopulations with
exquisite specificity. Specific allelic risk variants on interacting
cells can also be identified and investigated, which is important
given the observation that the level of HLA expression,
beyond a simple yes or no presence, impacts effector response
(Thananchai et al., 2007). Critically, samples pooled using
hashtags within a single analysis for overlaid visual inspection or
differential expression provide opportunity to detail similarities
or discrepancies between samples with unique clinical metadata
such as disease phenotype or mortality. These approaches provide
an opportunity to discover disease-specific cell populations and
targets for development of diagnostic tools or treatments.
The advent of microfluidics devices to accurately
encapsulate single cells in droplet suspension, barcoding,
and contemporary sequencing now delivers high-yield single-
cell data. Consequently, the needs have moved to data quality
assurance, management (informatics), analysis, and visualization,
specifically, how to qualify and interpret the immense amount of
complex data acquired. This traditionally necessitates specialist
bioinformatics support, coding expertise, and access to high-
end and robust computing software and servers, imposing
a significant cost of implementation to laboratories of all
sizes (Lähnemann et al., 2020). While data analysis tools are
typically developed at pace with advancements in sequencing
technologies, they are mostly limited to command line usage
of code, restricting their direct utility to research scientists
and clinicians. Moreover, although other platforms exist for
similar analyses, many are designed for singular and specific
utilities. To navigate, we present Visual Genomics Analysis
Studio (VGAS), a Windows-aligned, application-based intuitive
graphical user interface with performance-optimized hidden
code to drive comprehensive differential analyses, specifically
designed to allow basic and clinical researchers to interrogate
and dissect their own data and generate publication-ready
visuals for presentation on standard specification laptops. It
is designed to package existing tools in a single accessible
format, otherwise beyond the reach of basic researchers lacking
coding proficiencies for a variety of analysis options. Moreover,
VGAS, which also incorporates tools for sequence alignment
and viral integration site analyses, remains constantly updated
to incorporate user-defined features and recently developed
tools from this rapidly evolving field. Here, with reference to
screenshots and web-accessible tutorial videos, we introduce
the investigation capacity offered by single-cell analyses in
the context of VGAS. Critically, while our own translation
discussed within is tailored to focus on T-cell–mediated DHRs,
the functions offered are broadly applicable to single-cell study
of diverse samples and diseases. Here we demonstrate the utility
of VGAS using a 10x Genomics test dataset (available at: https:
//support.10xgenomics.com/single-cell-vdj/datasets/5.0.0/sc5p_
v2_hs_PBMC_10k_multi_5gex_5fb_b_t) in a VGAS-compatible
matrix file (available at https://www.iiid.com.au/software/vgas).
Utility of scTCR-Seq: Diversity and
Dominance Define Tissue and Antigen
Restriction
Within each individual, there is enormous diversity in TCRα–
β heterodimer repertoire, with an estimated 1013–1016 unique
TCR per person (Robins et al., 2009; Soto et al., 2020). In
T-cell–mediated DHRs, where specific HLA alleles expressed on
antigen-presenting cells are associated with immunogenic risk,
distinct TCRs have recently been reported to similarly restrict
response on the corresponding effector T-cells (Pan et al., 2019).
Specifically, through use of scTCR-seq, capable of ascertaining
α–β TCR pairs, Pan et al. identified a single, public TCRβ
CDR3 “ASSLAGELF” paired with TCRα CDR3 “VFDNTDKLI”
dominantly expanded in the blister fluid of multiple patients
with HLA-B∗15:02-restricted carbamazepine-induced SJS/TEN.
Importantly, this pairing was absent from healthy and tolerant
controls, and while present in peripheral blood mononuclear
cells from the same allergic patients, abundance was far
lower than detected in blister fluid. Such TCR specificity is
similarly identified for other immunodominant T-cell responses
in alternate disease settings, including infectious disease, such
as inflated HLA-B∗44:03-restricted CMV-specific CD8+ T-cell
responses to a defined immunodominant immediate-early 2
derived epitope (Attaf et al., 2018). Importantly, TCR specificity
may also provide an explanation for the skin-directed targeting
of cutaneous DHR by more widely distributed drugs, as the T-cell
tissue-resident repertoire is not consistent throughout the body
but compartmentalized into enclaves specific to tissue, in part
directed by previous antigenic exposures (Kumar et al., 2018).
Indeed, large populations of antigen-specific tissue-resident
memory (Trm) effector T-cells reside within organs, with those
in the skin and mucous membranes, typical microbial entry
sites, distributed as such for rapid activation following secondary
exposures. These microbially primed Trm cells are retained in
the skin but remain motile within, with recently demonstrated
capacity to proliferate (Behr et al., 2018). Such tissue-specific
locality of viral-specific T-cell effectors with epitope-restricted
TCR reactivity is the basis of the heterologous immunity
model, whereby drug antigens may cross-react with viral-specific
T-cells, driving the tissue-specific targeting of these reactions
(Pavlos et al., 2015). To this end, even simple comparative
analysis of TCR repertoire between affected and unaffected
sample may be informative as divergent expression would
be indicative of an active immune infiltrate, or conversely,
similarity may point to activation of tissue-retained effectors.
These considerations emphasize (a) the importance of collecting
clinically relevant tissue samples during early response to
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FIGURE 1 | Access tools for analysis of single-cell TCR-seq data. A variety of rapid access tools are available for analyses of single-cell TCR-seq data including (A)
comparative CDR3 length histogram, (B) gene frequency histogram for individual TCR genes (TRV α and β genes shown), (C) plate/well layout explorer for
plate-based assays listing paired CDR3 chain sequence, with options to show individual genes.
detect drug- and disease-specific dominant TCR expansion and
(b) the utility of scTCR-seq to detail such dominance and
provide α–β (and J chain) structure of the TCR for further
functional studies. Indeed, while traditional TCR analyses have
focused on expression of the β chain alone, including CDR3
spectra typing and flow cytometry–based detection kits, the
influence of the corresponding TCRα variable (TRAV) chain and
associated CDR3 to define antigen specificity is critical (Gras
et al., 2008; Rossjohn et al., 2015). Thus, scTCR-seq provides
complete human paired TCRα–β sequences enabling synthetic
reconstruction for functional validation with culprit antigen and
risk HLA as demonstrated by Pan et al. using an engineered
murine model (Pan et al., 2019).
VGAS: scTCR Analyses and Visualization
Tools
VGAS provides a platform for multidimensional analysis
of scTCR-seq with tools to visualize dominance of α–β
combinations and respective CDR3 sequences1 (TCR analysis
tutorials). Several one-click functions are available direct from
the scTCR-seq home menu screen after file upload, including
comparative graphical presentation of CDR3 lengths (see TCR
1https://www.iiid.com.au/software/vgas/tcranalysis/
analysis tutorials: CDR3 length) (Figure 1A), scatterplots to
represent TCRs common to samples (see TCR analysis tutorials:
scatterplot), and VDJ gene frequency histograms (see TCR
analysis tutorials: gene frequency) (Figure 1B) in linear or
logarithmic scaling with filters to exclude non-productive TCR
containing stop codons or out-of-frame alignments. Further, the
“CDR3/well plate explorer” function (Figure 1C) provides the
full detailed numerical list view of TCR pair representation in
each well to link with multimodal or functional data if performing
plate-based assays (Smart-Seq2).
More detailed visualization of dominance and holistic α–β
TCR pairings to detail clonality within and between samples
is possible via the main TCR analysis screen (Figure 2). Users
can select individual pairings of interest including α and β
chains or α and β CDR3 (Figure 2(1)). This selection is
visualized in the “paired gene frequency” domain (Figure 2(2)),
where one chain is depicted per pie and the colored edge
surrounding indicative of the number and proportion of pairings
with alternate corresponding chains. An active cursor hover
tool over each pie provides full details of each pairing and
comparative percentage expression (Figure 2(3)), with full details
of all pairings, inclusive of J chains and CDR3 observed in the
bottom window (Figure 2(4)) from which BLOSUM scoring can
ascertain sequence similarity for inference of similar restriction
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FIGURE 2 | scTCR-seq paired gene/CDR3 frequency window. The scTCR-seq analysis home screen window is divided into key domains to help direct analyses by
the user. (1) Gene pairings or corresponding CDR3 sequences can be selected for analysis by the user within the “display parameters” domain. (2) Representative
pie charts display proportion (and frequency) of TCR genes/CDR3 within the selected sample for initial indication of data. Each pie depicts one TCR chain with the
colored border representing proportional number of pairings with corresponding chains as selected in domain 1. The central chain can be switched using “Switch”
(highlighted red) in the parameters panel for alternate pairing view. (3) Hovering over select pies provides an information box with proportional representation (%) of
total pairings within. (4) Paired genes are displayed in grid format by selecting “display results grid” (highlighted red), which can be exported direct to Excel or Image
(highlighted red). (5) Circos plots can be generated for selected samples/pairings by clicking “Update” (highlighted red).
between different TCRs. From here, complex TCR visuals can be
generated using the “Generate Circos plots” domain, specifically
through selection of the “Update” toggle (Figure 2(5)). Circos
plots, linking one chain at the top to another at the bottom, are
best suited for holistic representation of clonality and are auto
colored to indicate dominant (red) compared to subdominant
(green) TCRs. The extent of a specific pairing between an α and β
chain is represented by the width of each connection (Figure 3A).
The settings for these Circos plots are configurable. For example,
plots may be set to visualize the α and β combinations but also α
or β and respective J chains, or α and β CDR3 sequences, which
ultimately define peptide specificity. For ease of identification,
each segment is annotated in the plot, which can be set to display
proportion and/or frequency of combinations. Scaled plots may
be exported to an image or raw data exported to Excel to produce
tables and access numerical representation of TCR within. Sankey
plots provide an alternate view for complex pairing interactions
between single α chains and multiple β chains or vice versa
(Figure 3B). This is often appropriate for a restricted data set,
i.e., top 20 pairings. Each chain can be moved independently up
or down the figure such that a TCR of interest can be listed as
required. Sankey plots therefore allow visualization of pairings
between two α genes or two β genes as are increasingly being
detected by single-cell sequencing. A new feature also allows the
TCR repertoire for a specific study to be instantly compared to
that of previous samples, stored as an active database, which can
be adapted for inclusion of external datasets, such that the user
can search for similar findings in other studies.
Utility of scRNA-Seq: Unsupervised
Holistic Dissection of Signature
Transcriptomes
For certain reactions such as abacavir hypersensitivity, TCR
responses appear to be polyclonal, suggesting a role for diverse
immunogenic antigens, and epitopes in keeping with the altered
peptide hypothesis (Redwood et al., 2019). However, as described
above for carbamazepine, single dominant TCRs have been
identified in patient blister during reaction, providing an antigen-
relevant functional marker to identify and characterize the
critical effector population driving destructive disease. While
output cellular functionality is largely imposed by surface
protein, the transcriptome is the vastly more complex precursor,
now almost completely measurable by scRNA-seq without
bias of preselect markers providing a holistic transcriptomic
signature for an individual cell. Algorithms, outlined by
Allaoui et al. (2020), then “pull” similar RNA signatures
together by k-means clustering, enabling visualized clusters in
t-distributed stochastic neighborhood embedding (t-SNE) or
uniform manifold approximation and projection (UMAP) plots
to be grouped and independently characterized direct from
sample suspension.
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FIGURE 3 | Circos and Sankey plots to display holistic clonality, dominance, and complex pairings. (A) Circos plots provide an overview of TCR pairing clonality and
dominance within a selected sample as shown for TRAV and TRBV pairings and can also be produced for paired CDR3. Alpha genes are listed at the top and paired
to respective β genes at the bottom with width and color (red to green) of each segment proportionate to comparative dominance of total functional TCR pairings.
(B) Sankey plot illustrating more complex gene interactions identified by sequencing, shown for TRAV-TRBV-TRAV triad, detailing clone frequency on y-axis.
Unbiased transcriptome analyses have recently proven utility
in defining critical cellular signatures with influence in varied
diseases including cancer (Dai et al., 2019; Zhang et al., 2020) and
infection (Bossel Ben-Moshe et al., 2019; Yao et al., 2019), driving
immunological understanding and identification of disease-
relevant biomarkers (Szabo et al., 2019; Cheng et al., 2020).
Similar application to DHRs remains limited to a handful of
studies, one detailing rechallenge response during HLA-restricted
positive patch test (Redwood et al., 2019), and another the
effector signature during a single case of treatment-refractory
drug reaction with eosinophilia and systemic symptoms (Kim
et al., 2020). In this latter study, the merit of unbiased scRNA-
seq to directly identify targetable biomarkers of disease was
clearly demonstrated when investigators found the JAK-STAT
pathway to be enriched in effectors directing the clinical
investigators to repurpose tofacitinib and effectively control
disease (Chattopadhyay et al., 2014). Application across samples
from patients with similar reactions may therefore provide
more distinct, reaction-specific biomarkers. However, scRNA-seq
captures the transcriptome at unparalleled resolution, posing a
challenge for managing, analyzing, and visualizing data. While
a range of software has been developed within tools such as R
for the analysis of high-dimensional datasets, the user must be
proficient in this type of programming and its strict framework,
reducing capacity for the researcher to freely explore their data.
VGAS: scRNA Analyses and Visualization
Tools
VGAS integrates a number of genomic dataset tools developed
for specific scRNA-seq analyses2 (RNA-seq plot viewer tutorials).
These include k-means clustering and UMAP/t-SNE plots,
varied differential expression analyses with statistical inference,
and plots to compare expression levels of specific transcripts.
2https://www.iiid.com.au/software/vgas/vgas-rnaseqplotviewer
Although suited to both UMAP and t-SNE, VGAS typically uses
UMAP, a well-documented non-linear dimensionality reduction
algorithm to convert high-dimensional scRNA-seq data into a
visual representation maintaining the global structure of data.
Compared to alternative t-SNE algorithms, UMAP presents a
faster method of clustering with reproducibility and conservation
of subtle differences in cellular populations (Becht et al., 2019).
Typically for data generated at our center, a single VGAS
plot view (VGAS.pv) file is released to the end-user after
bioinformatics quality control, for simple upload to VGAS, first
opening the single plot viewer control screen from which all
analyses are performed (Figure 4). The file is inclusive of all
batched samples in a combined UMAP; however, the master
normalized gene expression count (.csv) and metadata (.txt) files
are additionally provided should the user choose to recapitulate
the UMAP modeling. This can be directed through VGAS with
automated R plot functions for generation of typical Euclidean,
Manhattan, Cosine, Pearson, and Pearson 2 distributions. All
distributions may be selected, and plots toggled between as
required in the “Plot Viewer.”
The control “Plot viewer” screen is split into six key domains:
“Genes,” “Metadata,” “Groupings,” “Sample/cell metadata,”
“Color options,” and “TCR clonotypes,” respectively, depicted in
Figure 4(1–6). All metadata are accessible in the control panel
“Metadata” domain, e.g., patient ID, sex, age, etc., dependent
on that provided by the investigator, offering flexibility and
customizability to analyses (Figure 4(2)). The same “Metadata”
dropdown menu also holds information acquired during the
initial bioinformatics quality assurance and UMAP generation,
including cell cycle phase and assigned cell clusters according to
individual human cell atlases from which consensus is drawn.
This provides the user with an initial overview of the populations
present, which can then be highlighted on the UMAP (see RNA-
seq plot viewer tutorials: coloring plots by metadata) or grouped
with ease through one-click selection from the right click control
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FIGURE 4 | Workflow for analyses of scTCR–RNA-seq data using VGAS plot viewer window. The scTCR–RNA-seq analysis home screen window is divided into key
domains to help direct analyses by the user. (1) “Genes” panel lists all genes expressed with options to search for specific genes of interest (highlighted red), reorder,
and find literature determined groups of interest genes using the “Markers” dropdown tab or heatmap (highlighted red) individual genes on the UMAP for selected
sample. (2) “Metadata” is displayed with dropdown tabs to select data by sample, clinical metadata, or phenotype groupings defined by indexed flow data or via
unsupervised K means clustering on whole sample with consensus calling from reference atlas databases. (3) Grouped data/clusters appear in the “Groupings”
domain for selection and differential analyses using a range of statistical algorithms contained in the dropdown tab (highlighted red). Differential gene analysis results
provide p-value, p-adjusted, and fold change displayed in “Genes” panel. (4) Groups and plots can be fully color-customized in the “Color options” panel and
heatmap scales set to user preference. (5) Genes of interest, metadata, or groupings can be saved and set as metadata for further interrogation or grouping by
several parameters in the “Sample/cell metadata panel.” User-defined positive cutoff range for numerical data can be applied to filter samples using “Range” function
toggle (highlighted red). (6) scTCR-seq defined clonotypes can be set from whole data or distinct RNA-defined groups in the “TCR clonotypes” domain. Circos plots
can also be generated from within this panel. The “generate plots” function, bottom right (highlighted red), provides access to associated UMAP.
panel and which then appear in the “Groupings” domain (see
RNA-seq plot viewer tutorials: creating groups) (Figure 4(3)). Of
note, each group may be formatted by color, which will translate
to all subsequent visuals, through the “Color options” domain
(Figure 4(4)). More specific groupings according to select gene
expression (all genes listed in the left hand “Genes” domain
(Figure 4(1)) can then be developed through import to the
“Sample/cell metadata” domain (Figure 4(5)) by selecting either
a preselected “Metadata” or individual gene and selecting “Set as
metadata.” Four metadata columns are available for combined
parameter assessment; however, sequential groupings and
reapplication as metadata allow limitless combinations to build a
single signature. Imported RNA data are numerical, and the user
must define cutoffs for positivity/negativity before analysis. This
is possible through the single gene expression plot function to
graph the spectrum of gene expression from low to high, which,
in a manner similar to conventional histogram-based gating in
flow cytometry, provides the user guidance of where to set the
positive gate and may further identify bimodal or multimodal
expression within or between samples for further gating or low,
mid, or high expressors (Figure 5) (see RNA-seq plot viewer
tutorials: generating gene expression level plots). When defined,
the boundary value above a deemed positive can be input into
the “Range” function at the top of the “Sample/cell metadata”
domain, stripping those not meeting this inclusion criteria
from selection in the sample grid. The TCR repertoire for each
group, ascertained using the right-click function to generate the
correlating data in the “TCR clonotypes” domain (Figure 4(6)),
can be used to directly generate Circos plots.
Each group can be renamed and identified using the highlight
tool by opening a UMAP plot through the “Generate plots”
function, which has fully scalable x and y axes and formatting
functions for coloring, titles, and sizing. Multipanel UMAPs can
be generated in the plot viewer for easy comparison between
cell populations (Figure 6(1–5)). As alternative to groupings
defined by metadata (Figure 6(2–4)), groups can also be selected
directly via the UMAP using the highlight function in the plot
viewer to lasso an interest population before highlighting and
grouping these cells within the sample grid (Figure 6(5)). Such
analysis may be particularly useful for subclustering islands that
fall within the same cell-type metadata consensus, i.e., CD8+
T-cells that express dominant-TCR versus non-dominant TCR,
for authentic signature exploration.
Once two or more groups are created and selected in the
“Groupings” domain, the number of cells in each group is shown
in brackets, and then two analyses are typically done. First,
TCR clonotypes in a particular group can be set via the right-
click menu to appear in the bottom right “TCR clonotype”
domain if scTCR–RNA-seq was performed, listing combinations
of α–β pairs or respective CDR3 pairs in order of dominance
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FIGURE 5 | Gene expression plots to provide cutoffs for negative/positive expression or show differences between samples/groups. (A) Single or grouped gene
expression plots for all cells within a selected sample provides a platform to set cutoff for positivity and identify outlier expression or (B) highlight expression
differences between samples/plates.
(Figure 7). Of note, if scTCR-seq was not performed but a defined
interest TCR is known, gene selection for individual TRAV and
TRBV within the “Genes” panel will provide an indication of the
transcriptome of cells expressing those TRAV or TRBV genes.
Selected clonotype pairs (or specific single chains) may be added
to a separate group or highlighted on the UMAP to identify
the unique effector clusters for comparative scRNA-seq analyses
(Figure 7). This facilitates the second analysis, differential gene
expression, performed with selection of appropriate statistical
comparison test using the dropdown menu in the “Groupings”
section inclusive of t-test, Kruskal–Wallis, one-way analysis of
variance (ANOVA), Wilcoxon rank sum test, MAST, Limma,
paired t-test, paired ANOVA, or mean difference (see RNA-
seq plot viewer tutorials: performing differential gene expression).
The resulting differential analyses appear in a reordered “Genes”
section, ordered according to rank and with representation of
significance, relevant cell group (i.e., number 1 indicates this gene
is more highly expressed in the first grouping), and comparative
fold change in expression. More stringent significance can be
applied by the user through adjusting P-value according to Holm,
Hochberg, Hommel, Bonferroni, BH, BY, or false discovery rate,
and genes lists reordered according to user preference on fold
change or the number of cells expressing each gene (see RNA-seq
plot viewer tutorials: displaying number of cells with expression per
gene). Markers of interest for discovery studies may also be pulled
to the top of the “Genes” domain via a simple name search, via the
preset subsets tab, which contains predefined groups of markers,
or by import from clipboard (see RNA-seq plot viewer tutorials:
genes: sorting, searching and selecting).
Initial differential gene analyses are best visualized by volcano
plots incorporated into the “generate plots” function, separating
differential RNA by both statistical inference and fold change
(see RNA-seq plot viewer tutorials: generating volcano plots)
(Figure 8A). If groupings have been chosen on select markers,
these may be excluded from the plot as to prevent skewed
axes and more accurately dissect data. Alternatively, traditional
heatmap plots can be created using the “RNAseqHEAT” tool,
of particular utility when more than two populations are
being comparably assessed, again with user-adjustable heat
scaling (Figure 8B).
Expression of markers of interest may also be individually
displayed as a heatmap directly onto the UMAP by selecting
a specific marker in the gene list and accessing the one-click
function tab at the bottom of panel labeled “heatmap” (see
RNA-seq plot viewer tutorials: coloring plots using heatmaps)
(Figure 9). Given a UMAP is a two-dimensional (2D) image of
a 3D projection, respective arrow buttons plot those with highest
expression at the front or back of the plot, respectively (see RNA-
seq plot viewer tutorials: setting the draw order of plot points).
Importantly, to aid in the visualization of multidimensional
datasets, UMAPs may be aligned side-by-side to assess different
zoomed regions of the total UMAP or the same populations
from different samples and be similarly displayed as a heatmap
with user-defined formatting using the right-hand-side menu.
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FIGURE 6 | Multipanel UMAP investigation. (1) Sample/cell groupings created in “Groupings” panel can be plotted on multipanel UMAPs, with zoomed view
possible to focus on different regions of interest (2–5). (2) Groupings created from differentially expressed genes and metadata can be highlighted within the total cell
population, shown for CD3E+CD27+CCR7+ cells group defined in panel 1. (3) K-means clustering can be set in the scRNA-seq Plot View Options window and
illustrated within UMAP. (4) Cell types from unsupervised clustering can be separately colored on a UMAP with legend for visualization. (5) Cell clusters can be
“lassoed” on the UMAP and highlighted within the “Sample/cell metadata” grid for addition to distinct groups within “Groupings” for further analyses, named
“CellGroup_1” in groupings tab.
FIGURE 7 | scRNA-defined UMAP overlay of scTCR-seq. Single-cell defined functional TCR clonotypes can be imported for selected populations/samples,
displayed in order of dominance within the Plot View Options window, and highlighted on the scRNA-defined UMAP to pinpoint clusters with expression of dominant
or interest TCR (highlighted green).
Currently, plots may be compared up to four columns wide
and three rows deep on a single screen, but with additional
tabs available with rapid toggle function such that unlimited
parameters may be compared during a single analysis.
Significant differential expression does not necessarily infer
predominant expression in a subset. If more finite expression
level plots are required, this is performed in VGAS by simply
highlighting the interest genes and selecting “Generate violin/box
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FIGURE 8 | Tools to visualize differential gene expression. (A) Volcano plot for differential expression analysis between two groupings/samples. User-defined
thresholds can be set for fold change and significance, visualized according to color (red and green represent genes above different preselected fold change (FC)
and significance (p-value). Right-click menu provides options for addition and formatting of gene labels, plot coloring, and exclusion of selected genes.
(B) RNASeqHEAT enables generation of a heatmap of selected genes as shown on horizontal axis and with selected samples on vertical axis. Option panel
(highlighted in red) allows customization.
FIGURE 9 | Heatmapping scRNA-seq gene expression on UMAP. Combined sample or subpopulation UMAPs can be compared on a single screen simultaneously
providing an overview and more discrete dissection of sample. The “Zoom Strength” slider (highlighted red) enables focus on a particular region of interest directed
by grouped analyses for heatmapping gene expression between samples as dictated by interest of prior differential gene expression analyses.
plots by gene(s)” from the right-click drop menu in the
“Groupings” tab [see RNA-seq plot viewer tutorials: generating
gene plots (Violin and Box plots etc.)]. Alternatively, a specific
interest gene list in a specific order for presentation can be
selected by using the “Select from clipboard” function. An initial
window provides an overview of expression for each group
showing the minimum, average, and maximum expression, along
with the number of positive versus negative expressing cells for
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each selected gene (Figure 10A). Fully customizable violin or
box plots are readily generated with displayed average expression,
with added option to include jitters and/or heatmap colors to
align directly with other figures [see RNA-seq plot viewer tutorials:
coloring gene plot (jitter) points, coloring gene plot (jitter) points
using heatmaps; Figures 10B,C].
Utility of scCITE-Seq: Integrated
Single-Cell Delineation of Surface
Proteome
Transcriptome analyses provide highly complex cellular
signatures of disease, revealing extensive heterogeneity among
previously considered homogeneous populations (Bjorklund
et al., 2016). However, RNA transcription profiles do not
correlate completely with functional protein profiles, a
more tangible measure of output functionality and more
traditional diagnostic or therapeutic target. This divergence
in comparative expression is a product of several processes
including posttranscriptional processing, investigational error,
and variable protein turnover, but importantly, there remains
a direct RNA–protein concentration correlation, reported to be
approximately 40% (Vogel and Marcotte, 2012).
Surface protein is traditionally assessed by indexed flow
data, but this remains substantially limited by availability and
spectral overlap of fluorescent tags and thus provides a far
more restricted glimpse into the rich and diverse phenotypic
landscape truly expressed on each and every cell. Thus, in
recent years, unique tripartite DNA barcodes have been similarly
generated and tagged to protein-specific antibodies unique to
surface proteins of interest as to similarly sequence select surface
protein expression on the same cell as scTCR–RNA-seq. Two
separate modalities, CITE-seq and REAP-seq, respectively, were
developed by teams at the New York Genome Center (NYGC)
and Merck group (Peterson et al., 2017). While both are suitable
for analysis in VGAS, we use scCITE-seq, reviewed in detail by
the Stockieus laboratory at NYGC (Stoeckius et al., 2017), which
is fully integrated with scTCR–RNA-seq. As with flow and mass
cytometric methods, there remains a requirement to validate
titrations for each antibody combined in a single panel, but we
have found it straightforward to develop panels of more than
40 antibodies. We have optimized staining of different human
samples, including skin, blood, adipose tissue, and blister fluid,
using combinations of more than 45 oligo-tagged antibodies for
the investigation of DHR and other diseases. This technology
forms an integrated pipeline for holistic dissection of populations
by single-cell transcriptomics and comparative surface protein
markers and TCR.
VGAS: scCITE-Seq Analyses and
Visualization Tools
VGAS can incorporate scCITE-seq data, listing normalized count
files for each antibody in the “Metadata” dropdown menu
(Figure 11). Much of the analysis options described above
for scRNA-seq are possible for CITE-seq including differential
expression analyses with statistical inferences. Protein values
can also be displayed as a heatmap directly onto the same
UMAPs as scTCR–RNA-seq to delineate comparative RNA to
protein expression (Figures 12A,B). If required, protein markers
can be similarly explored and combined in the “Sample/cell
metadata” columns with specific TCR pairs or RNA interest
markers, generating a complete cell signature. Differential protein
analyses are possible between groups with inference determined
by varied statistical tests and heatmapping directly onto the same
UMAPs for comparable expression plots with corresponding
RNA (Figure 12C). Importantly, numerical positive expression
gates must be reset for protein data with different expression
ranges between markers. The right-click function allows the user
to set coverage depth for a particular antibody detailing the
numerical spread of expression, which appears in the depth bar
(see RNA-seq plot viewer tutorials: coloring plots using heatmaps)
(red highlight, Figure 11). This bar also provides detail of
expression density via a white-to-black scaling, with darker areas
representing the most abundant expression. This can be plotted
next to the heatmap scale on UMAPs to provide comparative
information on whether expression is high, mid, or low or even
multimodal. This complements the visual given the 3D nature
of the 2D UMAP such that some points may be hidden behind
others. Heatmap scaling may then be adjusted by the user such
to identify finite comparative expression even between two low-
expressing populations. More familiar flow-type histograms are
soon to be incorporated as an alternative gating and presentation
strategy to dissect multimodal expression given the observed
subtlety of variation on UMAP between similar but spatially
distinct clusters. Our own analyses to date (data not shown)
comparing flow-based and CITE-seq protein expression show
distinct overlap with similar population representation, in line
with that in the original pilot report from the Stockieus laboratory
(Stoeckius et al., 2017).
Brief Technical Overview and
Performance Benchmark
The requirements and complexity of “big data” meant loading
data files is typically slow, and subsequent analyses cumbersome.
Thus, the VGAS development team, critically bridging software
developers, bioinformaticians, laboratory scientists, and clinical
researchers all with extensive experience of handling genomic
data, has a major goal to develop and optimize performance
solutions for individual data acquisition functions. Successful in
this objective, VGAS incorporates non-standard and interlinked
algorithms from different programming languages, most typically
C sharp (C#), and provides highly efficient data structure
solutions to enable everyday use on standard specification
8- to 16-GB laptops. Enhanced storage efficiency is critical
for ease of file sharing and limits expense of long-term cold
data storage whereby a 10-GB normalized gene file can be
saved in an application specific (.VGASpv) plot view file
and zipped to 350 Mb. Furthermore, modular framework
of the application allows for inclusion of third-party tools
and development of novel analysis modules without affecting
functionality. Using R.Net to negate direct coding, VGAS
utilizes widely available R-based packages, hidden to the user,
adapting such to provide full customization of traditionally static
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FIGURE 10 | Differential gene expression plots. (A) “scRNA-seq gene expression and R plots” window allows user to define genes for inclusion in
single/comparative (B) violin and (C) boxplots with optional inclusion of jitters and defined heatmap coloring of groups.
R plots for scale, color, and resolution for rapid generation
of publication-quality images available in all bitmap formats
(tiff, png, jpeg) or as vector graphics. Importantly, VGAS
has been programmed by an experienced software engineer
through the entire software development “life cycle” using an
integrated development environment, Microsoft Visual Studio,
Frontiers in Genetics | www.frontiersin.org 12 June 2021 | Volume 12 | Article 642012
fgene-12-642012 June 11, 2021 Time: 17:32 # 13
Hertzman et al. VGAS: Multi-Omic Analysis Tool
FIGURE 11 | Overlay of surface protein expression (scCITE-seq) onto scTCR–RNA-seq analyses. Within the “RNA-seq plot viewer options” window, normalized
CITE-seq data are included in the “Metadata” panel, accessible via the dropdown tab (highlighted red). All applications discussed for scRNA-seq analyses are
applicable to protein with differential analyses between groups, selection into groupings or dissection via the “cell/sample metadata/domain. Depth bar (highlighted
red) provides detail of protein expression density via a white-to-black scaling with darker areas representing most abundant expression.
FIGURE 12 | scCITEseq data visualization on scRNA-defined UMAP. Gene and corresponding surface protein expression can be compared across individual cells
on the same unsupervised UMAP. (A) Cells highlighted with scRNA-seq defined positive CD4 expression. (B) Cells highlighted with surface CD4 expression using
scCITE-seq antibody. (C) CD4 scCITE-seq antibody expression displayed as a heatmap onto scRNA-defined UMAP.
which provides comprehensive testing tools for validation. To
provide a performance benchmarks, we utilized a standard
eighth-generation i7 Windows-based laptop with m.2 SSD as
now typically used in research institutions to load a 3-GB
file representing counts for more than 23,000 genes and 120
metadata (integer, numeric, and factor) across 30,000 cells in
less than 3 min. Active file upload used 4–5 GB, which was
maintained even during subsequent active display of 12, albeit
potentially unlimited, comparative UMAP plots. A crude sample
split into two groups of 15,000 cells was then used to benchmark
performance for differential gene expression analyses by one-way
ANOVA, taking less than 3 min. To ensure speed of analyses,
we recommend a laptop with 8-GB RAM and i5 processor or
equivalent as the minimum hardware specification.
Prior to investigator release, raw sequencing data are run
through a standard data normalization and quality-assurance
pipeline by our on-site bioinformatician. Importantly, VGAS
is independent of this standard pipeline, which uses open-
access tools, and may load data processed by any best-practice
approach. For droplet-based (10×) assays, Cell Ranger is used to
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align data from 10X-5′sc-RNA-TCR-CITE-seq, with processing
of antibody-derived reads by Seurat3 to analyze the multimodal
data and cluster cells based on both RNA and protein expression.
scRNA-seq measurements are normalized using SCTransform
and scale-factor transform method. scCITE-seq measurements
are normalized using centered-log ratio transformation in
Seurat. Cells with fewer than 200 genes and more than 10%
mitochondrial content are typically removed, but alternate
cutoffs may be defined by individual investigators. Furthermore,
genes with more than 0 counts in fewer than three cells are
also typically removed. Initial first-pass analyses are performed
using a combination of most current versions of Seurat for
unsupervised clustering and SingleR for cell-type prediction.
After normalization, data input for VGAS is a comma-separated
(.csv) normalized expression file and tab-separated metadata text
file (.txt), with the sample identifier as the first column and a
second column to display metadata as factor, integer, or numeric
value. This easily modifiable format enables additional metadata
to be included if not known at time of initial analysis. We
also provide a UMAP/t-SNE.csv file to view x, y coordinates;
however, data are also released as a merged VGAS plot view
(VGAS.pv) master file, which encompasses all three individual
files (normalized.csv, UMAP/t-SNE.csv, metadata.txt) for simple
one-click file open during software trial. All four test data files are
available to view input by download from our website4 (“VGAS
RNA-Seq Plot Viewer files” provides download link to all four
VGAS files (metdata.txt, normaliation.csv, UMAP.csv, VGAS.pv).
Summary and Future Development
Single-cell sequencing technologies are revolutionizing our
ability to understand complex cellular systems, providing
unparalleled ability to dissect the previously undefinable finite
cellular discrepancies that delineate disease phenotypes, patient
outcomes, and treatments. Moreover, because only 1,000–
2,000 cells are thought to be required for sufficient de novo
population dissection of any heterogeneous sample (Giladi
and Amit, 2018), it is feasible to explore even limited
clinical samples from relevant reaction sites. Collaborative
effort to map the entire human body by cell in the Human
Cell Atlas provides a critical reference resource to facilitate
interpretation of the results (Regev et al., 2017). For T-cell–
mediated disease such as DHRs, the integration of multifocal
scTCR–RNA–CITE-seq provides a pipeline to identify actively
responding tissue-based effectors driving destructive outcome,
first identifying dominantly expanded or newly recruited TCR,
before determination of unbiased transcriptome and select
proteome signature to delineate disease- and tissue-specific
biomarkers. This is possible not only for critical T-cell effectors,
but also all accessory populations, enabling more complete
understanding of the entire cellular microenvironment. These
single-cell technologies require investigators to be able to manage
and analyze their own big data. Investigators are at risk of
losing the understanding of their own data if they are completely
dependent on bioinformatics experts with the coding expertise
3https://satijalab.org/seurat/
4https://www.iiid.com.au/software/vgas
required for suitable data handling, quantification, and analysis.
VGAS is specifically designed to enable researchers to be
increasingly self-sufficient. One limitation is that the program has
to be administrator-distributed and linked to the highly specialist
sequencing pipelines available at a few specialist genomics
facilities worldwide. Critically, such sequencing is a core service
provided to external laboratories by our center with VGAS made
freely available for download to investigators. Access is also
provided to researchers who run their own sequencing; however,
there is a requirement for VGAS access that initial bioinformatics
normalization must be performed in collaboration. However,
prospective users can request for a 2-week trial of VGAS by
contacting software@iiid.murdoch.edu.au.
VGAS is strategically a non-web-based, Windows-aligned
application to minimize the effect of variable download speed,
allow analysis on the go, provide highest resolution images
for presentation, and, moreover, provide means to secure
confidential data to internal servers. Background coding has been
meticulously performance-optimized for different functions to
provide timely analyses that run on standard laptops without
need for high-end hardware and servers. With the fundamental
vision to provide researchers with intelligible means to access and
interrogate single-cell data and develop publication-ready figures,
a key ongoing principle remains user-directed development.
Next versions under construction are to include flow-type
histogram-based gating for alternative dissection of multimodal
RNA and protein expression and trajectory analyses of pseudo
time. Pseudo time, or “pseudotemporal reconstruction,” an
inference of time through the shortest transcriptomic path
between all linked populations, provides insight into both
the transcriptome-predictive before and after precursors and
exhausted counterparts of identified effector populations. This
enables conversion of what is a static snapshot of cellular
transcriptome in time into a continuum of cellular development
given the breadth of developmental stages for each cell type, based
on subtle discrepancies in similar gene expression (Haghverdi
et al., 2016). Importantly, interest transitions may be verified
by transposase-accessible chromatin sequencing (ATAC-seq) to
inform upon the plasticity from epigenetic modifications toward
a specific signature within a lineage as described by Gury-
BenAri for helper-like innate lymphoid cells in healthy mouse
intestine (Gury-BenAri et al., 2016). Thus, from a single sample,
a longitudinal view of cellular response may be obtained.
These additional analyses performed by our bioinformatics
team will not alter the input data, but rather extend the
existing metadata matrix, for example, by providing pseudotime
clustered populations with n = populations set by user. Further
information on our dedicated webpage (see text footnote 4)
will guide prospective users through the plethora of sequencing
technologies and associated analyses provided by VGAS.
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